Jasper Therapeutics holds annual stockholders meeting; 75% of shares represented
JSPR•Annual meeting results
Jasper Therapeutics held its annual shareholder meeting on July 31, 2026.
Shareholders selected two Class II directors to serve until the 2029 annual meeting.
PwC’s appointment as independent registered public accounting firm for fiscal 2026 was ratified.
